“CRISPR is science-driven, as we are learning from nature. We take advantage of our deep biological insights into the innovative design of protein-based biologics to improve their performance. Our strategy is to guide design, re-design, and selection, to de-risk development programs. We strongly believe in the partnership between academia, biotech, and the pharma industry”, says CEO CRISPR Pharma